These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 4145873
1. [Further studies on influenza-immunity by means of a mouse-lethal influenza virus strain A-Hong Kong. 3]. Herzberg K. Zentralbl Bakteriol Orig A; 1973 Feb; 223(2):173-9. PubMed ID: 4145873 [No Abstract] [Full Text] [Related]
2. [Further immunity tests on a mouse-lethal influenza virus strain Hong Kong with reference to its subtype. II]. Herzberg K. Zentralbl Bakteriol Orig; 1971 Feb; 216(4):421-7. PubMed ID: 5088345 [No Abstract] [Full Text] [Related]
3. [Immunity tests with a Hong Kong strain influenza virus lethal to mice]. Herzberg K. Zentralbl Bakteriol Orig; 1970 Apr; 213(3):298-303. PubMed ID: 5456375 [No Abstract] [Full Text] [Related]
4. The role of antineuraminidase antibody in immunity to influenza virus infection. Schulman JL. Bull World Health Organ; 1969 Apr; 41(3):647-50. PubMed ID: 5309490 [Abstract] [Full Text] [Related]
5. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain. Sidorova LA, Alekseyeva AK. Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209 [No Abstract] [Full Text] [Related]
6. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. Lipatov AS, Webby RJ, Govorkova EA, Krauss S, Webster RG. J Infect Dis; 2005 Apr 15; 191(8):1216-20. PubMed ID: 15776365 [Abstract] [Full Text] [Related]
8. The nature of the immunity evoked by infection of mice with avirulent influenza virus. Kurimura T, Hirano A, Okuno Y. Biken J; 1972 Mar 15; 15(1):31-7. PubMed ID: 5055346 [No Abstract] [Full Text] [Related]
9. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI. Vaccine; 2006 Nov 17; 24(47-48):6859-66. PubMed ID: 17050041 [Abstract] [Full Text] [Related]
10. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ. PLoS Med; 2007 Feb 17; 4(2):e59. PubMed ID: 17298168 [Abstract] [Full Text] [Related]
12. [Immunologic response of mice to influenza virus strains with different neuraminidase activity]. Loza-Tulimowska M, Brydak L. Med Dosw Mikrobiol; 1981 Feb 17; 33(2):119-22. PubMed ID: 7300508 [No Abstract] [Full Text] [Related]
14. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans. Závadová H. Acta Virol; 1973 Jul 17; 17(4):287-92. PubMed ID: 4148207 [No Abstract] [Full Text] [Related]
16. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Brett IC, Johansson BE. Virology; 2005 Sep 01; 339(2):273-80. PubMed ID: 15996702 [Abstract] [Full Text] [Related]
18. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. Qiu M, Fang F, Chen Y, Wang H, Chen Q, Chang H, Wang F, Wang H, Zhang R, Chen Z. Biochem Biophys Res Commun; 2006 May 19; 343(4):1124-31. PubMed ID: 16580631 [Abstract] [Full Text] [Related]
19. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Kreijtz JH, Bodewes R, van Amerongen G, Kuiken T, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Vaccine; 2007 Jan 08; 25(4):612-20. PubMed ID: 17005299 [Abstract] [Full Text] [Related]